Linda Holmquist Mengelbier

6PUBLICATIONS
31CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 25, 2026
The DNA/RNA autophagy protein SIDT2 as a novel neuropathological hallmark in Huntington disease.

Sanaz Gabery, Sofia Bergh, Chrisovalantou Huridou

|May 15, 2023
Retinoic acid promotes differentiation of WiT49- but not of CCG99-11 Wilms tumour cells.

Caroline Jansson, Linda Holmquist Mengelbier

|May 04, 2023
Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution.

Bahar Rastegar, Natalie Andersson, Alexandra Petersson

|Feb 12, 2020
Extensive Clonal Branching Shapes the Evolutionary History of High-Risk Pediatric Cancers.

Natalie Andersson, Bjorn Bakker, Jenny Karlsson

|Sep 25, 2018
The Iroquois homeobox proteins IRX3 and IRX5 have distinct roles in Wilms tumour development and human nephrogenesis.

Linda Holmquist Mengelbier, Simon Lindell-Munther, Hiroaki Yasui

|Jun 06, 2018
Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer.

Jenny Karlsson, Anders Valind, Linda Holmquist Mengelbier

Pageof 1

Frequent Collaborators

2 joint publications

Jenny Karlsson

2 joint publications

David Gisselsson

1 joint publications

Louise Cornmark

1 joint publications

Johan Staaf